High levels of immune cells in tumors may ID breast cancer pts most likely benefit from trastuzumab

(American Association for Cancer Research) Women with HER2-positive breast cancer who had the highest levels of immune cells in their tumors gained the most benefit from presurgery treatment with chemotherapy and trastuzumab, according to results presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news